Literature DB >> 14260069

SUPERVOLTAGE RADIATION THERAPY. USE OF THE LINEAR ACCELERATOR FOR TREATING OVARIAN ADENOCARCINOMA.

R H SAGERMAN, G E HANKS, M A BAGSHAW.   

Abstract

In a study of patients treated thus far by supervoltage radiation from the Stanford linear accelerator, the following conclusions were reached:Homogenous radiation in doses of 4,000 rads may be delivered to the upper abdomen and 5,500 rads to the lower abdomen and pelvis for the treatment of ovarian cancer by the proper utilization of modern super-voltage radiation sources. Patients with Stage 2 and Stage 3 lesions are best treated by total hysterectomy and bilateral salpingo-oophorectomy followed by total pelvic irradiation. Stage 4 disease was seldom controlled by high dose radiation therapy to the entire peritoneal cavity. An unusual histologic pattern has been found in the liver of three patients who died three to nine months after 4,000 to 5,000 rads had been given in a period of five or six weeks.

Entities:  

Keywords:  ADENOCARCINOMA; NEOPLASM RADIOTHERAPY; OVARIAN NEOPLASMS; RADIOTHERAPY, HIGH ENERGY

Mesh:

Year:  1965        PMID: 14260069      PMCID: PMC1515772     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  12 in total

1.  Is preservation of the uterus worthwhile?

Authors:  V M DALLEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-11

2.  A critical analysis of current therapy of carcinoma of the ovary.

Authors:  P RUBIN
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-11

3.  Has postoperative irradiation proved itself?

Authors:  P RUBIN; J W GRISE; R TERRY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-11

4.  Influence of oxygen tension on x-ray-induced chromosomal damage in Ehrlich ascites tumor cells irradiated in vitro and in vivo.

Authors:  E E DESCHNER; L H GRAY
Journal:  Radiat Res       Date:  1959-07       Impact factor: 2.841

5.  The Stanford medical linear accelerator. II. Installation and physical measurements.

Authors:  M WEISSBLUTH; C J KARZMARK; R E STEELE; A H SELBY
Journal:  Radiology       Date:  1959-02       Impact factor: 11.105

6.  Primary cancer of the ovary An analysis of 349 cases.

Authors:  S W KENT; D G MCKAY
Journal:  Am J Obstet Gynecol       Date:  1960-09       Impact factor: 8.661

7.  Treatment and prognosis in cancer of the ovary, with a review of a new series of 143 cases treated in the years 1944-1951.

Authors:  E W MUNNELL; H W JACOX; H C TAYLOR
Journal:  Am J Obstet Gynecol       Date:  1957-12       Impact factor: 8.661

8.  The Stanford medical linear accelerator. I. Design and development.

Authors:  E L GINZTON; K B MALLORY; H S KAPLAN
Journal:  Stanford Med Bull       Date:  1957-08

9.  The Stanford medical linear accelerator. III. Application to clinical problems of radiation therapy.

Authors:  H S KAPLAN; M A BAGSHAW
Journal:  Stanford Med Bull       Date:  1957-08

10.  Primary ovarian carcinoma.

Authors:  G J CARLIN; R J FRODEY
Journal:  Obstet Gynecol       Date:  1957-01       Impact factor: 7.661

View more
  1 in total

1.  Long-term survival in a case of stage IV carcinoma of the ovary treated with a single chemotherapeutic agent.

Authors:  N Akbiyik; E Solisio; L Alexander
Journal:  J Natl Med Assoc       Date:  1979-08       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.